
    
      All the patients will be included in the final analysis, with a total of 15 patients to be
      enrolled.

      Treatment will occur until disease progression, unacceptable toxicity or patient withdrawal.

      Tumor measurement and evaluation are going to be performed at every 6 weeks for the first 3
      months, then at every 9 weeks till progression, and then follow-up evaluation at every 12
      weeks thereafter end of study.
    
  